| Literature DB >> 33883946 |
Wei-Dong Bao1, Qi Jia2, Tao Wang2,3, Yan Lou2, Dong-Jie Jiang2, Cheng Yang2, Xinghai Yang2, Quan Huang2, Hai-Feng Wei2, Jian-Ru Xiao1,2.
Abstract
PURPOSE: To investigate risk factors for instrumentation failure (IF) in titanium (Ti) mesh reconstruction for thoracic and lumbar tumors. PATIENTS AND METHODS: The clinical data of patients with thoracic or lumbar tumors who received Ti mesh reconstruction via the posterior approach in our hospital from 2013 to 2018 were analyzed retrospectively. The observation indexes included sex, age, BMI, the vertebra resection mode, the number of resected vertebral segments, application of bone cement, radiotherapy, chemotherapy, revision or primary surgery, and primary tumor metastasis. Correlations between these factors and IF were analyzed by Kaplan-Meier survival and logistics regression analyses.Entities:
Keywords: instrumentation failure; thoracic and lumbar tumors; titanium mesh
Year: 2021 PMID: 33883946 PMCID: PMC8055544 DOI: 10.2147/CMAR.S294616
Source DB: PubMed Journal: Cancer Manag Res ISSN: 1179-1322 Impact factor: 3.989
Comparison of Parameters in Two Groups
| Risk Factor | N(%) | Failure | Chi-Square Value | P(Log Rank Test) |
|---|---|---|---|---|
| Gender | 0.615 | 0.433 | ||
| Male | 108 (39.33%) | 12 (11.11%) | ||
| Female | 70 (60.67%) | 5 (7.14%) | ||
| Age ≥60 | 1.444 | 0.229 | ||
| N | 50 (28.01%) | 15 (30.00%) | ||
| Y | 128 (71.91%) | 2 (1.56%) | ||
| BMI≥24 | 1.270 | 0.260 | ||
| N | 136 (76.40%) | 11 (8.19%) | ||
| Y | 42 (23.60%) | 6 (14.29%) | ||
| Total vertebral body resection | 12.119 | |||
| N | 86 (48.31%) | 1 (1.16%) | ||
| Y | 92 (51.69) | 16 (17.39%) | ||
| Vertebral resection segment | 19.838 | |||
| Single section | 130 (73.03%) | 4 (3.08%) | ||
| Multiple segments | 48 (26.97%) | 13 (27.08%) | ||
| Tumor resection location | 0.607 | 0.738 | ||
| Thoracic vertebrae | 107 (60.11%) | 11 (10.28%) | ||
| Thoracolumbar vertebrae | 28 (15.73%) | 2 (7.14%) | ||
| lumbar vertebra | 43 (24.16%) | 4 (9.30%) | ||
| Bone cement | 1.994 | 0.158 | ||
| N | 117 (65.73%) | 14 (11.97%) | ||
| Y | 61 (34.27%) | 3 (4.92%) | ||
| Radiotherapy | 15.279 | |||
| N | 150 (84.27%) | 9 (6.00%) | ||
| Y | 28 (15.73%) | 8 (28.57%) | ||
| Chemotherapy | 0.872 | 0.350 | ||
| N | 146 (82.02%) | 15 (10.27%) | ||
| Y | 32 (17.98%) | 2 (6.25%) | ||
| Revision | 2.820 | 0.093 | ||
| N | 142 (79.78%) | 10 (7.14%) | ||
| Y | 36 (20.22%) | 7 (19.44%) | ||
| Tumor nature | 2.146 | 0.143 | ||
| Benign tumor | 42 (23.60%) | 7 (16.67%) | ||
| Malignant tumor | 136 (76.40%) | 10 (7.35%) | ||
| Metastatic cancer | 3.338 | 0.068 | ||
| N | 103 (57.87%) | 14 (13.59%) | ||
| Y | 75 (42.13%) | 3 (4.00%) | ||
| Multiple tumors | 3.947 | |||
| N | 134 (75.28%) | 9 (6.72%) | ||
| Y | 44 (24.72%) | 8 (18.28%) |
Note: Bold values indicate statistically significant values.
Information Table of Instrumentation Failure
| No. | Sex | Age | Weight | Height | BMI | Revision | DV | TVBR | TES | BC | RT | CT | MT | BT |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | F | 33 | 45 | 160 | 17.50 | N | T1-T4 | Y | N | N | Y | N | N | Y |
| 2 | M | 32 | 69 | 170 | 24.00 | Y | T3-T5 | Y | Y | N | N | N | N | N |
| 3 | M | 54 | 75 | 168 | 26.60 | Y | T4-T6 | Y | Y | N | Y | N | N | N |
| 4 | M | 17 | 65 | 173 | 21.70 | Y | T4-T5 | Y | Y | N | N | N | N | Y |
| 5 | M | 64 | 62 | 167 | 22.23 | N | T5-T7 | Y | Y | N | Y | N | N | N |
| 6 | M | 26 | 75 | 185 | 21.90 | N | T8-T9 | Y | Y | N | N | N | N | Y |
| 7 | M | 16 | 80 | 173 | 26.70 | N | T11 | Y | Y | N | N | N | N | Y |
| 8 | M | 54 | 60 | 165 | 22.00 | N | T12-L1 | Y | Y | N | N | N | Y | N |
| 9 | F | 65 | 37 | 155 | 15.40 | N | T8-T9 | N | N | Y | Y | Y | Y | N |
| 10 | M | 52 | 70 | 170 | 24.20 | N | L2 | Y | N | N | N | N | N | Y |
| 11 | M | 34 | 65 | 172 | 21.90 | N | L2 | Y | Y | N | Y | N | N | N |
| 12 | F | 26 | 43 | 167 | 15.40 | N | L1 | Y | N | N | N | N | N | Y |
| 13 | F | 46 | 60 | 160 | 23.40 | Y | L2-L3 | Y | Y | N | Y | N | Y | N |
| 14 | F | 34 | 50 | 160 | 19.50 | N | T9-T10 | Y | Y | N | Y | N | N | N |
| 15 | M | 40 | 65 | 165 | 23.80 | Y | T10-11 | Y | Y | Y | N | N | N | N |
| 16 | M | 58 | 84 | 178 | 26.50 | Y | L4-L5 | Y | N | Y | N | N | N | Y |
| 17 | M | 54 | 76 | 168 | 26.90 | Y | T4-7 | Y | Y | N | Y | Y | N | N |
Information Table of Instrumentation Failure
| No. | IF | TPORFOL | TR | IFT:(Mos.) | Diagnosis | Main Symptoms |
|---|---|---|---|---|---|---|
| 1 | Double rods | Lo | N | 21 | Giant cell tumor of bone | Fatigue of right lower limb with movement disturbance. |
| 2 | Double rods | Upp | N | 47 | Invasive osteoblastoma | No obvious symptoms |
| 3 | Left rod | Lo | N | 20 | Chondrosarcoma | Nocturnal pain, and aggravation of standing and walking, weakness of both lower limbs, hypothermia of pain and temperature below the level of bilateral nipples, chest bandage sensation. |
| 4 | Right rod | Lo | N | 40 | Hemangioma | Chest and back pain, weakness of both lower limbs. |
| 5 | Double rods | Lo | Y | 31 | Chondrosarcoma | Pain |
| 6 | Left rod | Lo | N | 14 | Hemangioma | The left chest and back pain when bending down. |
| 7 | Double rods | Lo | N | 34 | Aneurysmal bone cyst | Pain |
| 8 | Double rods | Lo | N | 19 | Spinal metastasis of renal cell carcinoma | Pain |
| 9 | Screw loose | Lo | N | 47 | Spinal metastasis of esophageal cancer | The affected skin is red, swollen and ulcerated. |
| 10 | Nut and pedicle screw Loose | N | N | 31 | Eosinophilic granuloma | Pain |
| 11 | Double rods | Lo | N | 38 | Invasive osteoblastoma | Pain |
| 12 | Double rods | Lo | N | 32 | Giant cell tumor of bone | Pain |
| 13 | Titanium mesh fracture | N | Y | 24 | Spinal metastasis of lung cancer | Pain |
| 14 | Double rods | Lo | N | 58 | Epithelioid osteoblastoma | No obvious symptoms. |
| 15 | Left rod | Lo | N | 59 | Multiple chondrosarcoma | Hear the sound of metal breaking on the back when walking. |
| 16 | Titanium mesh dislocation | Upp | N | 56 | Giant cell tumor of bone | Pain |
| 17 | Screw loose | N | N | 27 | Chondrosarcoma | No obvious symptoms. |
Abbreviations: Y, yes; N, no; IF, instrumentation failure; TPORFOL, the position of rod fracture or loosening; TR, tumor recurrence; IFT, IF time.
Figure 1Kaplan–Meier survival curve of overall survival in patients. The survival rate of IF was 96.84%, 89.69%, 77.42% and 43.44% at 24, 36, 48 and 60 months after operation in all patients studied, respectively.
Figure 2Typical Case 1: A 26-year-old female patient with L1 giant cell tumor of bone. (A and B) Positive and lateral X-ray films of the lumbar spine when the patient was admitted for the first time. Pathological fracture of the lumbar vertebra, noticeable compression of the vertebral body, and spine instability were observed. (C and D) X-ray films of the positive and lateral positions of the lumbar vertebrae after tumor resection. The L1 vertebral body was resected intraoperatively, showing good positive and lateral positions of the instrumentation. (E and F) Positive and lateral X-ray films with double rods broken 32 months after operation. Broken rods occurred at the upper edge of the titanium mesh, and the titanium mesh was embedded into the upper vertebral body. (G and H) The coronal plane of lumbar CT and 3D reconstruction shows broken rods and spinal instability. (I) No tumor recurrence s found on T2-weighted MRI of the lumbar vertebrae. (J and K) The positive and lateral x-ray film after revision, fixed with double rods during the operation.
Figure 3Typical case 2: internal fixation failure occurred in a 32-year-old male patients 47 months after T3-5 invasive osteoblastoma operation. (A and B) The positive and lateral X-ray internal fixation was good before the rods are broken. (C and D) The positive and lateral X-ray of the broken rods. (E) No tumor recurrence found on T2-weighted MRI of the lumbar vertebrae. (F and G) The positive and lateral X-ray film after revision, fixed with double rods during the operation. Simultaneously, a pair of pedicle screws were added to the seventh cervical vertebra for fixation.
Cox Logistics Regression Analysis of Factors Related to Instrumentation Failure
| Risk Factor | B | HR(95% CI) | p-value |
|---|---|---|---|
| Total vertebral body resection | |||
| Y | 2.152 | 8.600 (1.101–67.197) | |
| N | |||
| Vertebral resection segment | |||
| Single section | 1.479 | 4.389 (1.338–14.402) | |
| Multiple segments | |||
| Radiotherapy | |||
| Y | 1.327 | 3.771 (1.429–9.952) | |
| N | |||
| Multiple tumors | |||
| Y | 0.420 | 1.522 (0.567–4.083) | 0.404 |
| N | |||
Note: Bold values indicate statistically significant values.
Figure 4Kaplan-Meier curves. (A) By total vertebral body resection; (B) by the number of resected vertebral segments; (C) by radiotherapy.